Journal of Infection Prevention is the professional publication of the Infection Prevention Society. The aim of the journal is to advance the evidence base in infection prevention and control, and to provide a publishing platform for all health professionals interested in this field of practice.
The journal has a rapidly developing, multi-professional author and readership base, including:
- Infection prevention and control professionals
- Public health and health protection specialists
- Pharmacists with an interest in antimicrobial agents
- Allied health professionals
- Primary care professionals including general practice staff, dental staff and sexual health specialists.
The Editorial Board welcome manuscripts on a range of scientific and practice topics and are keen to support new authors. If you wish to join our panel of peer reviewers or the Editorial Board to help maintain the high quality of our publication, please contact the Editor at firstname.lastname@example.org
This journal is a member of the Committee on Publication Ethics (COPE).
Journal of Infection Prevention is the professional publication of the Infection Prevention Society.
The aim of the journal is to advance the evidence base in infection prevention and control, and to provide a publishing platform for all health professionals interested in this field of practice. Journal of Infection Prevention is a bi-monthly peer-reviewed publication containing a wide range of articles:
Original primary research studies
Qualitative and quantitative studies
Reviews of the evidence on various topics
Practice development project reports
Guidelines for practice
Overviews of infectious diseases and their causative organisms
Audit and surveillance studies/projects
The journal has a rapidly developing, multi-professional author and readership base, including:
Infection prevention and control professionals
Public health and health protection specialists
Pharmacists with an interest in antimicrobial agents
Allied health professionals
Primary care professionals including general practice staff, dental staff and sexual health specialists.
The multi-professional Editorial Board are keen to support new authors and are happy to provide guidance on planning and writing papers for publication.
|Ms Paula Cockcroft||Vernacare Ltd, UK|
|Dr Judith Dyson||University of Hull, UK|
|Ms Tracey Gauci||Welsh Government, UK|
|Ms Linda Hosie||Royal Berkshire NHS Foundation Trust, UK|
|Mr Martin Kiernan||University of West London, UK|
|Gary Thirkell||Leeds Teaching Hospitals NHS Trust, UK|
|Dr Saber Yezli||Global Centre for Mass Gathering Medicine, Saudi Arabia|
|Dr Michael Borg||Mater Dei Hospital, Malta|
|Dr Andre Charlett||Public Health England, UK|
|Dr Evonne Curran||Health Protection Scotland, UK|
|Ms Carole Fry||Public Health England, UK|
|Professor Dinah Gould||Cardiff University, UK|
|Mr Peter Hoffman||Public Health England, UK|
|Professor Heather Loveday||University of West London, UK|
|Dr Outi Lyytikainen||Hospital Infection Program, Finland|
|Professor Shaheen Mehtar||University of Stellenbosch, South Africa|
|Dr Maria Luisa Moro||Agenzia Sanitaria e Sociale Regionale Emilia-Romagna, Italy|
|Dr Tyrone Pitt||NHS Blood & Transplant, UK|
|Dr Jacqui Prieto||University of Southampton, UK|
|Professor Jacqui Reilly||Health Protection Scotland, UK|
|Dr Claire Rickard||Griffith University, Australia|
|Dr Julie Robotham||Public Health England, UK|
|Professor Sanjay Saint||VA Ann Arbor Healthcare System and University of Michigan Medical School, USA|
|Professor Hugo Sax||University Hospital Zurich, Switzerland|
|Professor Patricia Stone||California Hospital Medical Center, USA|
|Ms Julie Storr||IPC Consultant, UK|
|Professor Charles Vincent||University of Oxford, UK|
|Dr Michael Whitby||University of Queensland, Australia|
|Dr Neil Wigglesworth||Guy’s and St Thomas’ NHS Foundation Trust, UK|
- Article types
- Editorial Policies
2.1 Peer review policy
2.5 Declaration of conflicting interests
2.6 Research ethics and patient consent
2.7 Clinical Trials
2.8 Reporting Guidelines
- Publishing Policies
3.1 Publication Ethics
3.2 Contributor's publishing agreement
3.3 Open Access and author archiving
- Preparing your manuscript
4.1 Word processing formats
4.2 Artwork, figures and other graphics
4.3 Supplementary material
4.4 Journal layout
4.5 Reference style
4.6 English language editing services
- Submitting your manuscript
5.1 How to submit your manuscript
5.2 Title, keywords and abstracts
5.3 Corresponding author contact details
- On acceptance and publication
6.1 SAGE Production
6.2 Access to your published article
6.3 Online First publication
- Further Information
This Journal is a member of the Committee on Publication Ethics
This Journal recommends that authors follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals formulated by the International Committee of Medical Journal Editors (ICMJE)
There are no fees payable to submit or publish in this journal.
Please read the guidelines below then visit the Journal’s submission site http://mc.manuscriptcentral.com/jips to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.
Only manuscripts of sufficient quality that meet the aims and scope of Journal of Infection Prevention will be reviewed.
As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.
The Journal welcomes original manuscripts of the following types:
Full-length, original research articles
These should contain a maximum of 4,000 words, including the structured abstract of up to 250 words, text, acknowledgements and references. Each table or figure counts as 200 words.
These may be up to 5,000 words (excluding references) and provide a detailed overview and analysis of research evidence on an aspect of infection prevention and control. Reviews will also be submitted to a peer review process. Authors are advised to discuss the proposed review with the editor prior to submission.
Letters referring to topics raised by papers already published in the Journal of Infection Prevention or elsewhere, or novel findings meriting rapid dissemination. They should not contain structural headings or a summary, and should be a maximum of 1,000 words with no more than 5 references. Letters will not normally be peer-reviewed, but may be shown to the authors of the article being commented on, who will be invited to respond, should they wish to do so.
These should contain up to 1,500 words, no more than 2 figures or tables, and up to 10 references. The format should be the same as a full length article, i.e introduction or background/methods/results/discussion and conclusion. Short reports will be subject to the same peer review process as full-length articles.
These should contain up to 3,000 words, including abstract and references, and provide a succinct and balanced summary of existing research on a relevant, current topic of interest. Authors are advised to discuss the proposed commentary with the editor prior to submission.
Table 1: A summary of the paper types published in the Journal of Infection Prevention:
Maximum Word length
Full-length, original research
Structured Abstract of 250 words
No more than 50
250 words, not structured
No more than 150
No more than 5
100 words, not structured
No more than 20
250 words, not structured
No more than 50
1.1 Format of articles
It is the authors' responsibility to ensure the manuscript is in the required format before submission. Papers that are submitted with references or other features that do not comply with these instructions will be returned to their authors and will not be considered for publication until they have been resubmitted. If you would like to discuss your paper prior to submission, please contact the Editor at: email@example.com.
Title Page: This should show the title, names of all authors (but not their degrees) and the institution or department where they work. It should also include the name, address, telephone and email address of the corresponding author to whom the proofs and correspondence should be sent.
Front page of main document: In addition to the title of the article, the front page should include the following information:
- Word count
- Approval obtained for reproduction or modification of material published elsewhere (if applicable)
- Sources of funding (if applicable)
- Commercial affiliations (if applicable)
Abstract: This should not exceed 200 words, should briefly explain the study and for all full-length original articles must be structured with the following headings:-
- Aim/ Objective
Since this will be the first, and perhaps the only, part of the paper that is read it is essential that it conveys the key elements of the work.
Keywords: Authors should provide keywords from their summary. These should be chosen carefully to ensure that those indexing and searching for papers in the field are able to locate your work.
Main text of article: Headings and subheadings may be used in the article with the following structure recommended:
Background: A brief statement outlining the purpose and context of the paper and aim of the study.
Methods: A description of the approach taken to the study, setting, design and methods used, and where relevant or appropriate, the process used to obtain ethical approval and patient/participant consent. Please see section 2.8 for guidance on consulting relevant reporting guidelines for different types of study.
Results: Description of study results with no discussion of their significance or relationship to other work in the field. Information may be conveyed in text, or in figures or tables, but should not be repeated in more than one format.
Discussion: Description of the significance of the findings including their relationship with other research in the field and where appropriate their application in practice. It should include any weaknesses or limitations of the study. New results should not be introduced in the discussion.
Acknowledgments: All contributors who do not meet the criteria for authorship should be listed in an `Acknowledgements’ section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support. Authors should disclose whether they had any writing assistance and identify the entity that paid for this assistance. Any acknowledgements should appear first at the end of the article prior to the References.
References: All work referred to in the manuscript must be fully cited using the Harvard system of referencing (see section 6.3).
Tips for effective writing for publication
It is important that the work should be written carefully and accurately, ruthlessly removing superfluous or ambiguous words. Please check the spelling, especially unusual or scientific terms or names. Start with a single sheet of paper outlining the order of ideas and arguments. Before starting to write, read some articles in respected journals that and look at the way facts are presented, arguments are made and the style of language used.
The journal's policy is to obtain at least two independent reviews of each article. It operates a double-blind reviewing policy in which the author and reviewer’s names are mutually concealed – as such; submitted manuscripts should contain no identifying information.
Referees will be encouraged to provide substantive, constructive reviews that provide suggestions for improving the work and distinguish between mandatory and non-mandatory recommendations.
The editor welcomes papers that contribute toward the development and understanding of infection prevention and control theory and practice. All manuscripts accepted for publication are subject to editing for presentation, style and grammar. Any major redrafting is agreed with the author but the editor's decision on the text is final.
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
- Made a substantial contribution to the concept and design, acquisition of data or analysis and interpretation of data,
- Drafted the article or revised it critically for important intellectual content,
- Approved the version to be published.
Authors should meet the conditions of all of the points above. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.
2.3.1 Writing Assistance
Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance”).
It is not necessary to disclose use of language polishing services. Please supply any personal acknowledgements separately to the main text to facilitate anonymous peer review.
The Journal of Infection Prevention requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
It is the policy of Journal of Infection Prevention to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’.
For guidance on conflict of interest statements, please see the ICMJE recommendations here
Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.
For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.
Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.
Please also refer to the ICMJE Recommendations for the Protection of Research Participants
The Journal of Infection Prevention conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
The Journal of Infection Prevention advises authors to consult with the relevant EQUATOR Network reporting guidelines in order to ensure high quality reporting of studies. The appropriate reporting guideline depends on the type of study. For example, for reports of outbreaks or interventions to prevent infection authors should refer to the ORION Checklist, for systematic reviews of evidence refer to PRISMA and for epidemiological studies to the STROBE guidelines. All of these reporting guidelines are available on the EQUATOR network website.
All randomized controlled trials submitted for publication should include a completed Consolidated Standards of Reporting Trials (CONSORT) flow chart as a cited figure, and a completed CONSORT checklist as a supplementary file. Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives
SAGE acknowledges the importance of research data availability as an integral part of the research and verification process for academic journal articles.
JIP requests all authors submitting any primary data used in their research articles alongside their article submissions to be published in the online version of the journal, or provide detailed information in their articles on how the data can be obtained. This information should include links to third-party data repositories or detailed contact information for third-party data sources. Data available only on an author-maintained website will need to be loaded onto either the journal’s platform or a third-party platform to ensure continuing accessibility. Examples of data types include but are not limited to statistical data files, replication code, text files, audio files, images, videos, appendices, and additional charts and graphs necessary to understand the original researchThe editor can also grant exceptions for data that cannot legally or ethically be released. All data submitted should comply with Institutional or Ethical Review Board requirements and applicable government regulations.
SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway
The Journal of Infection Prevention and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of articles published in the journal. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked using duplication-checking software. Where an article is found to have plagiarised other work or included third-party copyright material without permission or with insufficient acknowledgement, or where authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article (removing it from the journal); taking up the matter with the head of department or dean of the author’s institution and/or relevant academic bodies or societies; banning the author from publication in the journal or all SAGE journals, or appropriate legal action.
Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive licence agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
The Journal of Infection Prevention offers optional open access publishing via the SAGE Choice programme. For more information please visit the SAGE Choice website. For information on funding body compliance, and depositing your article in repositories, please visit SAGE Publishing Policies on our Journal Author Gateway.
Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions on the SAGE Journal Author Gateway
Preferred formats for the text and tables of your manuscript are Word DOC, RTF, XLS. LaTeX files are also accepted. The text should be double-spaced throughout and with a minimum of 3cm for left and right hand margins and 5cm at head and foot. Text should be standard 10 or 12 point. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.
For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines
The Journal of Infection Prevention is printed in colour, please provide figures, graphics etc in colour for them to appear in colour online and in print.
This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. These will be subjected to peer-review alongside the article. For more information please refer to our guidelines on submitting supplementary files, which can be found within our Manuscript Submission Guidelines page.
The Journal of Infection Prevention conforms to the SAGE house style. Click here to review guidelines on SAGE UK House Style.
The Journal of Infection Prevention adheres to the SAGE Harvard reference style. Click here to review the guidelines on SAGE Harvard to ensure your manuscript conforms to this reference style.
All references in the text must be cited from primary sources and should include the authors' names and date of publication in date order, e.g. (Skelton, 1997; Edwards, 1998; Whitehead, 2000). Where there are three or more authors, the first author's name followed by 'et al' is acceptable in text, e.g. (Troillet et al, 1999), but all authors must be cited in the reference list. Page numbers should be included in the text for all quotations, e.g. (Harthog, 2000: 136).
Reference to a journal article should include the author's surname and initials, date of publication, title of the paper, name of the journal, volume and issue number and its first and last page numbers, e.g. Ayliffe G. (2000) Evidence Based Practices in Infection Control. Journal of Infection Control 1(4): 5-9.
Reference to a book should include the author, date of publication, title, publisher and town of publication, e.g. Kirkwood E and Lewis C. (1989) Understanding Medical Immunology Second Edition: John Wiley and Sons: Chichester.
Chapters in edited books should include the additional detail of chapter title and page numbers e.g. Stevens R and Jones R. (1993) Functional Bowel Disorders. In: Gastrointestinal Problems in General Practice (Jones R. ed). Oxford University Press: Oxford: 126-35.
Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.
The Journal of Infection Prevention is hosted on SAGE Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit http://mc.manuscriptcentral.com/jips to login and submit your article online.
IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Online Help.
Please supply a title, short title, an abstract and keywords to accompany your article. The title, keywords and abstract are key to ensuring readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your abstract and select your keywords by visiting the SAGE Journal Author Gateway for guidelines on How to Help Readers Find Your Article Online
Provide full contact details for the corresponding author including email, mailing address and telephone numbers. Academic affiliations are required for all co-authors. These details should be presented separately to the main text of the article to facilitate anonymous peer review.
Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be sent by PDF to the corresponding author and should be returned promptly.
SAGE provides authors with online access to their final article.
Online First allows final revision articles (completed articles in queue for assignment to an upcoming issue) to be published online prior to their inclusion in a final journal issue which significantly reduces the lead time between submission and publication. For more information please visit our Online First Fact Sheet
Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the Journal of Infection Prevention editorial office as follows: firstname.lastname@example.org